Euclises
United States · $2.2M raised
- Website
- euclises.com
- Total Funding
- $2.2M
- Last Round
- $2.0M Series AApr 2015
- Rounds
- 2
About
Euclises Pharmaceuticals is a drug discovery and development company creating next-generation cancer and pain therapies that block tumor immune evasion.
Summary
Euclises is a Biotech company based in United States. It has raised $2.2M in total across 2 rounds, most recently a $2.0M Series A round in Apr 2015. Investors include Cultivation Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2015
Sign up to see all 2 rounds
Angel through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/euclises"><img src="https://indexed.vc/api/badge/company/euclises" alt="Euclises on Indexed.vc" width="260" height="76" /></a>